Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

September 8, 2021

Primary Completion Date

November 13, 2021

Study Completion Date

November 13, 2021

Conditions
Healthy
Interventions
DRUG

GLPG4716

From Day 3 to Day 14, participants will receive GLPG4716 tablets once daily in fasted state. On Day 8 GLPG4716 will be administered in fed state.

DRUG

Midazolam

On Days 1, 3 and 13, participants will receive a single oral dose of MDZ as an oral solution in fasted state.

Trial Locations (1)

QC H3P 3P1

Altasciences, Montreal

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galapagos NV

INDUSTRY